Prostate Cancer
Cardiovascular risk profile of veteran men beginning androgen deprivation therapy - Abstract
September 25, 2014
New era of the treatment of CRPC in Japan - Abstract
September 25, 2014
Predicting the Gleason sum of a patient with a prostate biopsy core Gleason ≤ 7 and a prostate biopsy core Gleason ≥ 8 - Abstract
September 25, 2014
Effect of histological inflammation on total and free serum prostate-specific antigen values in patients without clinically detectable prostate cancer - Abstract
September 25, 2014
Resource utilization and use of life-extending therapies and corticosteroids in prostate cancer patients with corticosteroid-sensitive comorbidities - Abstract
September 25, 2014
Enzalutamide in European and North American men participating in the AFFIRM trial - Abstract
September 25, 2014
Comparison of NaF and FDG PET/CT for assessment of treatment response in castration-resistant prostate cancers with osseous metastases - Abstract
September 25, 2014
Utility of an initial adaptive bladder volume control with ultrasonography for proton-beam irradiation for prostate cancer - Abstract
September 24, 2014
Maximum tumor diameter adjusted to the risk profile predicts biochemical recurrence after radical prostatectomy - Abstract
September 24, 2014
How to minimize lymphoceles and treat clinically symptomatic lymphoceles after radical prostatectomy - Abstract
September 24, 2014
Affecting African American men's prostate cancer screening decision-making through a mobile tablet-mediated intervention - Abstract
September 24, 2014
Prevention of erectile dysfunction after radiotherapy for prostate cancer - Abstract
September 24, 2014
Docetaxel followed by abiraterone in metastatic castration-resistant prostate cancer: Efficacy and predictive parameters in a large single center cohort - Abstract
September 24, 2014